119-hr727

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 727 Introduced in House

    (IH) ]

<DOC>

119th CONGRESS
 1st Session
 H. R. 727

To amend title IV of the Public Health Service Act to prohibit sale or 
 transactions relating to human fetal tissue.

_______________________________________________________________________

 IN THE HOUSE OF REPRESENTATIVES

 January 24, 2025

Mr. Scott Franklin of Florida (for himself, Mr. Weber of Texas, Ms. Van 
 Duyne, Mr. Gosar, Mr. Self, Mr. Rogers of Kentucky, Mr. Ellzey, Mrs. 
Miller of Illinois, Mr. Babin, Mr. Rutherford, Mr. Webster of Florida, 
and Mr. Moolenaar) introduced the following bill; which was referred to 
 the Committee on Energy and Commerce

_______________________________________________________________________

 A BILL

To amend title IV of the Public Health Service Act to prohibit sale or 
 transactions relating to human fetal tissue.

 Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

 This Act may be cited as the ``Prohibiting Abortion Industry's 
Lucrative Loopholes Act''.

SEC. 2. PROHIBITING SALE OR TRANSACTIONS RELATING TO HUMAN FETAL 
 TISSUE.

 

Section 498B

    (e) of the Public Health Service Act (42 U.S.C. 289g-
2

    (e) ) is amended by striking paragraph

    (3) and inserting the following 
new paragraph:
 ``

    (3) The term `valuable consideration' includes--
 ``
        (A) any payment made or debt incurred;
 ``
        (B) any gift, honorarium, or recognition of value 
 bestowed;
 ``
            (C) any price, charge, or fee which is waived, 
 forgiven, reduced, or indefinitely delayed;
 ``
            (D) any loan or debt which is canceled or 
 otherwise forgiven;
 ``
        (E) the transfer of any item from one person to 
 another or provision of any service or granting of any 
 opportunity for which a charge is customarily made, 
 without charge or for a reduced charge; and
 ``
        (F) any payments associated with the 
 transportation, implantation, processing, preservation, 
 quality control, or storage of human fetal tissue.''.
 <all>